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The poly(ADP-ribose)polymerases Tankyrase 1/2
(TNKS/TNKS2) catalyze the covalent linkage of
ADP-ribose polymer chains onto target proteins,
regulating their ubiquitylation, stability, and function.
Dysregulation of substrate recognition by Tank-
yrases underlies the human disease cherubism.
Tankyrases recruit specific motifs (often called
RxxPDG ‘‘hexapeptides’’) in their substrates via an
N-terminal region of ankyrin repeats. These ankyrin
repeats form five domains termed ankyrin repeat
clusters (ARCs), each predicted to bind substrate.
Here we report crystal structures of a representative
ARC of TNKS2 bound to targeting peptides from six
substrates. Using a solution-based peptide library
screen, we derive a rule-based consensus for Tank-
yrase substrates common to four functionally con-
served ARCs. This 8-residue consensus allows us
to rationalize all known Tankyrase substrates and
explains the basis for cherubism-causing mutations
in the Tankyrase substrate 3BP2. Structural and se-
quence information allows us to also predict and
validate other Tankyrase targets, including Disc1,
Striatin, Fat4, RAD54, BCR, and MERIT40.
INTRODUCTION
ADP-ribosylation of proteins or other acceptors is catalyzed by
a family of 22 known or putative human ADP-ribosyltransferases,
which use nicotinamide adenine dinucleotide (NAD+) as a source
for transferring ADP-ribose onto their substrates, either as
monomers or by constructing poly(ADP-ribose) chains (reviewed
in Ame´ et al., 2004; reviewed in Hassa and Hottiger, 2008; re-
viewed in Hottiger et al., 2010; Kleine et al., 2008). Protein
ADP-ribosylation reportedly occurs on aspartate, glutamate,1340 Cell 147, 1340–1354, December 9, 2011 ª2011 Elsevier Inc.asparagine, arginine, lysine, cysteine, phosphoserine, and diph-
thamide residues (reviewed in Hottiger et al., 2010). As a large
posttranslational modification of substantial negative charge,
protein poly(ADP-ribosyl)ation (PARsylation) can influence pro-
tein fate through several mechanisms, including a direct effect
on protein activity, recruitment of binding partners that recognize
poly(ADP-ribose), or by affecting protein turnover.
Tankyrase is a multidomain poly(ADP-ribose)polymerase
(PARP) with an N-terminal region rich in ankyrin repeats, a
sterile-alpha motif (SAM) domain that mediates Tankyrase oligo-
merization, and a C-terminal catalytic PARP domain (reviewed
in Hsiao and Smith, 2008; Smith et al., 1998) (Figure 1A). The
N-terminal ankyrin repeats cluster into five domains (‘‘ankyrin
repeat clusters,’’ ARCs), whose precise structures remain to be
determined (Seimiya and Smith, 2002). The human genome
encodes two similar Tankyrases, TNKS and TNKS2 (PARP5/
ARTD5 and PARP6/ARTD6). Both recruit a variety of substrates
involved in a broad range of biological functions (Table 1). Tank-
yrases recognize linear peptide motifs consisting minimally of
six consecutive amino acids with high apparent degeneracy in
sequence (the TNKS-binding motif, extended to 8 amino acids
as shown below) (reviewed in Hsiao and Smith, 2008; Sbodio
and Chi, 2002; Seimiya et al., 2004; Seimiya and Smith, 2002).
Thismakes rationalizationof knownsubstrates and theprediction
of additional substrates difficult. To date, TNKS-binding motifs
have been validated or proposed in 17 proteins (Table 1). In
many of the studied systems, binding of target proteins by Tank-
yrase results in their PARsylation. Tankyrase targets some of
its substrates for ubiquitylation and proteasome-dependent deg-
radation, as observed for TERF1/TRF1 (Chang et al., 2003; Smith
et al., 1998), AXIN (Huang et al., 2009), MCL1 (Bae et al., 2003),
and 3BP2 (see accompanying manuscript by Levaot et al., 2011
[this issue of Cell]). In the case of 3BP2, mutations in the TNKS-
binding motif that abolish Tankyrase recognition underlie the
human disease cherubism, a condition characterized by inflam-
matory lesions of the facial bone (see accompanying manuscript
by Levaot et al., 2011). These findings highlight the essential role
of substrate targeting in Tankyrase biological function.
Here we uncover the structural and functional basis of how
Tankyrases recognize their substrates and derive a compre-
hensive set of rules that explain the basis for cherubism
disease and enable the accurate prediction of Tankyrase
substrates.
RESULTS
The TNKS2 N Terminus Contains Minimally
Four Substrate-Binding Sites
Previous work indicated that the N-terminal ankyrin repeat
region of Tankyrase has five ARCs (Seimiya et al., 2004; Seimiya
and Smith, 2002), each predicted to bind substrate (Figure 1A).
A bacterially expressed TNKS2 fragment containing the entire
ankyrin repeat region (residues 20–800) bound a fluorescein-
labeled 3BP2 substrate recruitment peptide (LPHLQRSPPDGQ
SFRS) with an apparent affinity of 0.5 ± 0.1 mM (using a one-
site binding model; Figure 1B, left). TNKS2 fragments corre-
sponding to ARCs 1, 4, and 5 and a double-ARC construct
comprising both ARCs 2 and 3 (but not ARCs 2 or 3 individually)
were also solubly expressed and purified. ARCs 1, 4, and 5 each
bound the 3BP2 peptide (dissociation constant [KD] = 6.9 ±
2.8 mM, 6.3 ± 1.2 mM, and 1.3 ± 0.2 mM, respectively; Figure 1B,
right). The ARC2-3 unit also bound the 3BP2 peptide (KD = 2.3 ±
0.3 mM), but we could not determine whether it contained one or
two functional peptide-binding sites (Figure 1B, right). We
concluded that there are four, or possibly five, functional
substrate-binding sites in the TNKS2 N terminus, in agreement
with previous work (Seimiya et al., 2004; Seimiya and Smith,
2002).
Structural Analysis of an ARC and Prediction
of Its Peptide-Binding Pocket
A boundary-optimized form of ARC4 was crystallized in apo-
and 3BP2 peptide-bound forms, and X-ray crystal structures
were determined by molecular replacement (see Table S1 avail-
able online for data collection and refinement statistics and
Extended Experimental Procedures for details). ARC4 consists
of a stack of five ankyrin repeats (Figures 1A and 1C), the central
three of which (repeats 2–4) possess a characteristic ankyrin
repeat architecture (loop–helix1–loop–helix2–loop). Ankyrin
repeat 1 is cryptic in nature, with an atypically long helix1,
whereas ankyrin repeat 5 has an atypically short helix1. As in
other ankyrin repeat proteins, the terminal loops of each ankyrin
repeat extend from the pair of hydrophobically packed, antipar-
allel helices, forming a sheet of b hairpins (Figure 1C). The
continuous succession of ankyrin repeats generates a concave
surface at the ‘‘front’’ face of the ARC (according to the view
shown in Figure 1C).
Projection of residue conservation for ARCs 1–5 onto the
ARC4 surface identified a conserved concave surface in the
central region of the ARC (Figure 1D, left). Omission of
ARC3 from the conservation analysis increased the degree
of sequence conservation on the mapped surface (Figure 1D,
right). As demonstrated below, the conserved region corre-
sponds to the peptide-binding pocket, and its lack of conser-
vation in ARC3 reflects the fact that ARC3 does not bind
substrates.Overview of the ARC4:3BP2 TNKS-Binding Motif
Complex
In the ARC4:3BP2 peptide complex, the 3BP2 peptide of se-
quence LPHLQRSPPDGQSFRS (core binding motif as de-
scribed below is underlined) adopts an extended conformation
and binds to a pocket situated centrally to the ARC, perpendic-
ular to its longitudinal axis (Figure 2A). The pocket is located
within the peptide-binding site predicted by sequence conserva-
tion and is entirely formed by the central three ankyrin repeats
(2–4). As such, the flanking ankyrin repeats, 1 and 5, likely serve
as structural caps (Figure S1B), as noted for other ankyrin repeat
proteins (reviewed in Forrer et al., 2003; reviewed in Li et al.,
2006). The anticipated shortness of linkers (0 to 9 residues)
between autonomously folding ARCs (Figure 1C) likely limits
the flexibility of an otherwise beads-on-a-string architecture.
Description of the TNKS2 ARC4:3BP2 TNKS-Binding
Motif Interface
The 8-residue 3BP2 core sequence RSPPDGQS is engaged by
four groups of peptide-coordinating residues in ARC4: arginine
at position 1 (R4153BP2) of the 3BP2 peptide is engaged by an
‘‘arginine cradle,’’ glycine at position 6 (G4203BP2) is engaged
by an ‘‘aromatic glycine sandwich,’’ the central residues
between the arginine and glycine (positions 2–5) are engaged
by a ’’central patch,’’ and two C-terminal residues (positions 7
and 8) are engaged by two C-terminal contact residues (Figures
2B and S2A).
Four TNKS2 side chains contribute to the extensive arginine
cradle (Figure 2C): W591TNKS2 packs against the nonpolar por-
tion of the R4153BP2 side chain. F593TNKS2 establishes a cat-
ion-p interaction, whereas E598TNKS2 and D589TNKS2 form salt
bridges with the guanidinium group of R4153BP2.
Two TNKS2 tyrosines, Y536TNKS2 and Y569TNKS2, form the
aromatic glycine sandwich (Figure 2C). The absence of a side
chain at G4203BP2 allows for a close approach of the peptide
main chain to the ARC such that a hydrogen bond is formed
between the main-chain carbonyl of G535TNKS2 and the main-
chain amide of Q4213BP2 at position 7.
Nine residues comprise the central patch of the peptide-
binding pocket (Figures 2C and S2A). R525TNKS2 forms a hy-
drogen bond with the side chain of S4163BP2 at position 2, the
main-chain carbonyl groups of S4163BP2 and P4173BP2 at posi-
tions 2 and 3, respectively, and, via a water molecule, the
main-chain amino and carbonyl groups of S4163BP2. TNKS2
makes no contact with the solvent-exposed side chain of
P4173BP2; however, P4173BP2 directs the peptide backbone
toward a subpocket into which the side chain of P4183BP2 at
position 4 inserts. Within this subpocket, L560TNKS2 confers
hydrophobic contact, whereas the main chains of N565TNKS2
and H564TNKS2 and the side chain of S568TNKS2 confer Van der
Waals contact. The side chain of Y569TNKS2 additionally coordi-
nates P4183BP2 through a hydrogen bond to the main-chain
carbonyl group.
A subpocket of the central patch defined by F532TNKS2,
D521TNKS2, S527TNKS2, and R525TNKS2 accommodates the
D4193BP2 side chain at position 5. S527TNKS2 forms a direct
hydrogen bond with D4193BP2, whereas D521TNKS2 and the
main-chain amino group of R525TNKS2 and S527TNKS2 formCell 147, 1340–1354, December 9, 2011 ª2011 Elsevier Inc. 1341
Figure 1. Functional Characterization of an Ankyrin Repeat Cluster
(A) Domain organization of human TNKS2. The ankyrin repeats group into five ARCs of five ankyrin repeats each. ARC4 was crystallized (indicated byA). SAM,
sterile-alpha motif domain; PARP, poly(ADP-ribose)polymerase catalytic domain.
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Table 1. Previously Identified and Proposed Tankyrase Binders
Protein Name Function Reference(s)
Proven Tankyrase Binders/Substrates with Identified TNKS-Binding Motifs
TERF1/TRF1 telomere binder and negative regulator
of telomere length
(Cook et al., 2002; Kaminker et al., 2001; Sbodio and Chi, 2002;
Sbodio et al., 2002; Smith et al., 1998)
AXIN1/2 tumor suppressor in the Wnt signaling pathway (Huang et al., 2009)
LNPEP/IRAP integral-membrane aminopeptidase (Chi and Lodish, 2000; Sbodio and Chi, 2002;
Sbodio et al., 2002)
NUMA1 mitotic spindle regulator (Chang et al., 2005a, 2005b; Sbodio and Chi, 2002)
MCL1 apoptosis regulator (Bae et al., 2003)
TNKS1BP1/TAB182 largely uncharacterized Tankyrase binder (Sbodio and Chi, 2002; Seimiya and Smith, 2002)
EBNA1 protein of Epstein Barr virus; functions
in DNA replication and transcriptional regulation
(Deng et al., 2002, 2005)
FNBP1/FBP17 cytoskeletal regulator (Fuchs et al., 2003)
BLZF1 regulator of protein transport; precise function unknown (Zhang et al., 2011)
CASC3 regulator mRNA biogenesis (Zhang et al., 2011)
3BP2 signaling adaptor protein; mutated in cherubism (Levaot et al., 2011)
Proposed Tankyrase Interactors with Putative TNKS-Binding Motifs
GRB14 signaling adaptor (Lyons et al., 2001)
HOXB2 homeobox transcription factor (Sbodio and Chi, 2002)
PPP1R12C/MBS85 polymorphic variant of the protein phosphatase 1
regulatory subunit 12C
(Sbodio and Chi, 2002)
TAX1BP1 apoptosis regulator (Sbodio and Chi, 2002)
CACNA1S alpha 1S subunit of the voltage-dependent L-type
calcium channel
(Sbodio and Chi, 2002)
USP25 ubiquitin-specific protease (Sbodio and Chi, 2002)
Proposed Tankyrase binders were identified by yeast-two-hybrid analysis; GRB14 was confirmed as an interactor by coimmunoprecipitation.water-bridged hydrogen bonds to the D4193BP2 side chain. Simi-
larly, S527TNKS2, D556TNKS2, and N565TNKS2 collaborate in a
water-bridged hydrogen-bonding network to the main-chain
amino group of D4193BP2. The N565TNKS2 side chain also
hydrogen bonds with the main-chain carbonyl group of
D4193BP2. Lastly, a water molecule bridges the Y536TNKS2 and
D4193BP2 side chains.
Although the residues preceding the arginine at position 1 are
poorly ordered and unlikely to contribute critical contacts, two
C-terminally located amino acids of the peptide are directly
coordinated by ARC4 side chains: the side chain of H571TNKS2
hydrogen bonds with the main-chain carbonyl group of
Q4213BP2 at position 7, whereas the side chain of K604TNKS2
hydrogen bonds with the side chain of S4223BP2 at position 8
(Figure 2C). The structural order of the three C-terminal peptide
residues is largely attributable to crystal contacts with no major
direct contacts to the corresponding ARC.(B) FP binding assay for the full ankyrin repeat region of TNKS2 (left) or the indicate
ARC2-3 double-cluster. ARC2mut-3 specifies an L245Wmutation that disrupts 3B
nonlinear regression using a one-site total bindingmodel; n.q., not quantifiable. n
error values, standard error of the fit.
(C) Left, ribbon representation of apo-ARC4 with individually colored ankyrin rep
identity with secondary structure elements for ARC4 above. ARC4 residues cont
(D) Side-chain conservation across the TNKS2 ARCs mapped onto the ARC4 s
conservation across all five TNKS2 ARCs; right, surface conservation upon omis
See Figure S1 for domain architecture of substrates analyzed in this study and cThe four ARC4:3BP2 complexes present in the asymmetric
unit are highly similar (Figure S2B). A comparison of the apo-
and peptide-bound forms of ARC4 demonstrates that the pep-
tide-binding pocket is fully formed prior to peptide coordination
(Figure S2C).
Validation of the ARC4-Peptide Interaction Surface
by Mutagenesis
To biochemically validate the ARC4:3BP2 structure, we intro-
duced mutations into the peptide-binding pocket predicted to
impair binding while preserving the ankyrin repeat fold. We
produced and purified 14 well-folded ARC4 mutant derivatives
(Figures 3A and S3) and performed fluorescence polarization
(FP) assays to test each for substrate (3BP2) binding (Fig-
ure 3B). As noted above, wild-type (WT) ARC4 bound the
3BP2 peptide with micromolar affinity (KD = 6.4 ± 0.6 mM)
(Figure 3B).d single- and double-ARC constructs (right). ARCs 2 and 3were analyzed as an
P2 peptide binding to ARC2 (see Figure 3). KD are indicated where derivable by
= 3 separate experiments performed in technical duplicate; error bars, SEM; KD
eats. Right, sequence alignment of all five TNKS2 ARCs colored by sequence
acting the 3BP2 peptide (see Figure 2) are labeled withC and numbered.
urface. The corresponding sequence alignment is shown in (C). Left, surface
sion of ARC3.
apping features of ARC4.
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Figure 2. Structural Representation of the ARC4:3BP2 Targeting Peptide Complex
(A) Ribbon (left) and surface (right) representations of ARC4 colored as in Figure 1Cwith the 3BP2 peptide shown in stick representation. The 8 amino acids of the
3BP2 peptide that constitute the TNKS-binding motif (RSPPDGQS) are shown in magenta with colored heteroatoms (oxygen, red; nitrogen, blue); remaining
peptide residues are shown in white with colored heteroatoms.
(B) Stereo surface representation of the ARC4:3BP2 complex with the 3BP2 peptide shown as in (A). Key ARC4 residues participating in 3BP2 peptide coor-
dination are color-coded; 3BP2 residues are labeled.
(C) Stereo ribbon representation of the peptide-binding pocket with the 3BP2 peptide and relevant contact residues in ARC4 shown as sticks. Coloring is as in (B).
Dashed lines connect selected polar neighbors.
See Figure S2 for additional structural representations. See also Table S1.
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Mutation of arginine cradle residues (W591A, F593A, E598A,
WFE591/593/598AAA, D589T) strongly impaired peptide binding
to ARC4 so that a KD could not be determined (Figure 3B). Muta-
tion of Y536, one of the glycine sandwich tyrosines (Y536A),
had a weak effect on peptide binding (KD = 17.7 ± 3.5 mM),
whereas mutation of Y569 (Y569A, YY536/569AA) abolished
measurable peptide binding. TNKS2 residues coordinating the
central positions 2–5 of the 3BP2 peptide also proved critical
for peptide binding. An N565A mutation strongly reduced
peptide binding (KD = 30.2 ± 8.9 mM), whereas the R525A,
R525D, S527A, and a pocket-filling L560W mutation each
reduced peptide binding below quantifiability. These results vali-
date our structural observations and establish a set of residues
critical for 3BP2 targeting peptide engagement by an ARC.
Notably, despite the conservation of K604TNKS2 as a basic
residue (see Figure 1C), its mutation to alanine had no measur-
able effect on 3BP2 peptide binding. As discussed below,
K604 makes a more important contribution to binding of target-
ing peptides from other Tankyrase substrates.
Based on conservation of residues within the validated sub-
strate-binding surface of ARC4, we can rationalize the peptide-
binding function of the different ARCs: like ARC4, ARCs 1, 2,
and 5 possess the required infrastructure for substrate binding,
whereas ARC3 does not (see ARC alignment in Figure 1C). We
therefore anticipated that the ARC2-3 construct discussed
above contains only a single peptide-binding site formed by
ARC2. Introduction of an L245Wmutation into ARC2 (equivalent
to the L560W mutation in ARC4) in the context of ARC2-3
(ARC2mut-3) abolished ARC2-3 binding to the 3BP2 peptide,
confirming this prediction (Figure 1B). The TNKS2 N terminus
therefore contains four functional 3BP2 peptide-binding sites.
If one considers the presence of four sites within the TNKS2 N
terminus that contribute similarly to peptide binding, the overall
affinity of the penta-ARC construct (Figure 1B, left) is in agree-
ment with the affinities of the individual ARCs (Figure 1B, right).
ARCs 1, 2, 4, and 5 Display Redundancy
for 3BP2 Binding
The binding behavior of ARCs 1, 2, 4, and 5 toward 3BP2 (Fig-
ure 1B) suggests that these ARCsmay be functionally redundant
for 3BP2 recognition. To test this prediction, we serially intro-
duced inactivating L-to-W mutations (equivalent to the L560W
mutation in ARC4) into each of the ARCs of TNKS2 in the context
of the full ankyrin repeat region spanning all five ARCs
(TNKS2(20–800); Figure 3C). Bacterially expressed His6-GST-
TNKS2(20–800) efficiently recruited purified, recombinant full-
length His6-3BP2 in a GST pull-down assay, whereas neither
His6-GST alone nor the corresponding TNKS2 mutant with five
mutated ARCs (xxxxx) bound 3BP2 (Figure 3D). In agreement
with our prediction, all five single-ARC mutants (x2345, 1x345,
12x45, 123x5, 1234x) showed robust binding to 3BP2, demon-
strating that no single ARC is critical for 3BP2 binding by Tank-
yrase (Figure 3D).
To determine whether any of the five ARCs is sufficient for
3BP2 recruitment in the context of the full TNKS2 N terminus,
we mutated four out of five ARCs, leaving only a single ARC
intact (1xxxx, x2xxx, xx3xx, xxx4x, xxxx5). As expected, ARC3
alone (xx3xx) did not bind 3BP2, whereas ARCs 1, 2, 4, and 5alone did bind, but with reduced apparent affinities (Figure 3D).
Reduced binding might reflect the simple reduction of the
number of available binding sites and/or the loss of avidity
effects.
To extend our binding analysis to full-length Tankyrase, we
coexpressed WT MYC-TNKS2 or a set of mutant derivatives
with either WT FLAG-3BP2 or cherubism derivatives (murine
R413Q and P416H) of FLAG-3BP2 in mammalian (HEK293T)
cells (Figure 3E). Following immunoprecipitation of WT FLAG-
3BP2, we detected robust binding of TNKS2 and any of its
single-ARC mutants but not TNKS2 xxxxx or xx3xx (Figure 3E).
The cherubic FLAG-3BP2 variants (murine R413Q or P416H)
did not recruit Tankyrase detectably. These observations sup-
port a degree of functional redundancy across ARCs 1, 2, 4,
and 5 for 3BP2 recruitment. A complete disabling of substrate
recognition by Tankyrase in cells thus may require the inactiva-
tion of all four functional ARCs.
ARCs 1, 2, 4, and 5 Display Similar Substrate
Recognition Abilities, and TNKS-Binding Motifs
Are Octapeptides
We expanded our analysis from 3BP2 to other Tankyrase
targets. Using the FP binding assay, we assessed ARC4 binding
to proven or predicted targeting peptides from known or pro-
posed Tankyrase substrates (3BP2, NUMA1, HOXB2, LNPEP,
FNBP1, TNKS1BP1, a polymorphic variant of PPP1R12C, CAC-
NA1S, MCL1, USP25, TERF1, AXIN1, TAX1BP1, EBNA1, and
GRB14; see Table 1) (reviewed in Hsiao and Smith, 2008). All
peptides except for those from TAX1BP1, EBNA1, GRB14, and
nonpolymorphic PPP1R12C bound ARC4 with comparable
(micromolar) affinities (Figures 4A and 4B).
Binding analysis of other ARCs to the same panel of peptides
revealed similar peptide-discriminating abilities with only slight
differences in overall binding affinities. On average, ARC2 (i.e.,
ARC2-3) and ARC5 bound TNKS-binding motif peptides more
strongly than ARC1 or ARC4 (Figures S4A and S5 and Table
S2). Among ARCs 1, 2, 4, and 5, ARC1 was the weakest peptide
binder, whichmay be rationalized by two phenylalanines in place
of the tyrosines in the aromatic glycine sandwich (see sequence
alignment in Figure 1C). This would abolish a hydrogen bond
between the residue equivalent to Y569 in ARC4 with the
substratemain chain (see Figure 2C). Based on the hyperconser-
vation of peptide-binding surface residues within each ARC
across different species, we reason that the relative binding
strength and function of each ARC will be conserved across
life forms with Tankyrases that possess a penta-ARC organiza-
tion (Figure S4B).
TNKS-binding motifs are typically referred to as ‘‘hexapepti-
des,’’ and the limited overall sequence conservation outside a
6-amino-acid stretch suggested that the hexapeptide contains
the chief determinants for Tankyrase binding (Figure 4A). To
revisit the actual extent of the TNKS-bindingmotif, we performed
an alanine scan across a 9-amino-acid range for two prominent
TNKS-binding motifs, 3BP2 and AXIN1. We then tested the
effect of each mutation on ARC4 association in the FP assay
(Figure 4C). The WT 3BP2 peptide bound ARC4 with a KD of
3.8 ± 0.4 mM. Mutation of the residues preceding the invariant
arginine at position 1, Q-1A, and mutation of residues atCell 147, 1340–1354, December 9, 2011 ª2011 Elsevier Inc. 1345
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positions 7 and 8 had little effect on ARC4 binding (KD values of
4.6 ± 1.1 mM, 3.9 ± 0.9 mM, and 3.8 ± 0.7 mM, respectively). Strik-
ingly, mutation of the invariantly conserved R1 and G6 positions
to alanine (R415A and G420A) abolished quantifiable binding of
ARC4 to the peptide, similar to the GST pull-down results ob-
tained with the TNKS-binding motif peptide of LNPEP (Sbodio
and Chi, 2002). Mutation of the less conserved peptide residues
at positions 2–4 (S416A, P417A, P418) only had small effects (KD
values of 5.7 ± 0.8 mM, 7.3 ± 1.1 mM, 8.8 ± 1.5 mM, respectively).
The D419Amutation at position 5 resulted in a larger decrease in
peptide affinity (KD = 70.0 ± 39.5 mM), indicating a more critical
contribution of aspartate at this site. The binding determinants
for 3BP2 therefore map to a hexapeptide stretch. In the case
of AXIN1, however, binding to ARC4 was sensitive to mutations
across an octapeptide region (positions 1 to 8; Figure 4C).
As observed for 3BP2, the arginine and glycine residues at posi-
tions 1 and 6 were absolutely required for binding. Mutation of
residues at positions 2, 3, 4, 5, and 8 resulted in less dramatic
decreases in affinity, whereas mutation of the residue at position
7 had no negative effect on binding. Unlike for 3BP2, mutation of
residue 8 weakened the ARC4-AXIN1 interaction about 2.3-fold
(from 6.5 ± 1.4 mM to 15.1 ± 4.0 mM).
In summary, the four functional ARCs display similar binding
properties, and ARC-binding determinants map to a TNKS-
binding motif of 8 amino acids. The highly conserved arginine
and glycine residues at positions 1 and 6 of the binding motif
are critical anchor residues essential for peptide binding to
ARC4. The limited sampling of the alanine scan, however, did
not fully explain the remarkable diversity of residues at other
positions of functional TNKS-binding motifs (explored below).
A Structural Comparison of Multiple TNKS-Binding
Motif Peptides
The variability of the central peptide residues in various Tankyr-
ase ligands is striking (see Figure 4A). For example, the TNKS-
bindingmotif peptide ofMCL1contains three consecutiveproline
residues (RPPPIGAE), whereas that of TERF1 lacks prolines alto-
gether (RGCADGRD). To elucidate whether such diverse ligands
employ the same binding mode for ARC interaction, we crystal-
lized ARC4 bound to peptides from TERF1, MCL1, LNPEP,
NUMA1, and FNBP1 (Tables S1 and S6). All peptides bound in
a similar configuration observed for the 3BP2-derived peptide
(Figure 4D); notably, peptides without prolines adopted a geom-
etry similar to proline-containing peptides. Thus, despite consid-
erable variation in interaction motif sequence, all substrates
investigated employ a common ARC-binding mode.Figure 3. Probing the ARC4 Interaction Surface by Site-Directed Muta
(A) Schematic representation of the ARC4:3BP2 peptide interaction. ARC4 resid
(B) FP binding assays comparing WT ARC4 and mutants. KD are indicated where
quantifiable. n = 3 separate experiments performed in technical duplicate; error
(C) Outline of ARC mutations.
(D) Equivalency of ARCs 1, 2, 4, and 5 for 3BP2 binding. GST-fusion proteins of th
their ability to recruit purified full-length murine His6-3BP2 in a GST pull-down a
PonceauS-stained membrane of bound material; top panel, western blot to dete
(E) WT and the indicated mutant derivatives of full-length MYC-TNKS2 were coe
HEK293T cells. FLAG-3BP2 was immunoprecipitated. Bottom panels, lysates sh
(3BP2) or anti-MYC (TNKS2) antibodies.
See Figure S3 for additional information.Unfortunately, we were unable to obtain crystals for ARC4
bound to AXIN1/2, one of the most prominent Tankyrase targets
(Huang et al., 2009; Zhang et al., 2011). To probe whether
AXIN1 employs an ARC-binding mode similar to that of the other
targets analyzed, we investigated binding of the AXIN1-target-
ing peptide to the 14 ARC4 pocket mutants described above.
Most of the mutations that impaired binding to the 3BP2
substrate peptide also perturbed binding to the AXIN1 peptide,
arguing that a common binding mode is employed (compare
Figures 3B and S4C). However, binding of the AXIN1 peptide
was strikingly sensitive to mutation of the C-terminal contact
residue K604TNKS2 to alanine (Figures 3B and S4C). Position 8
in the TNKS-binding motifs of AXIN1 and AXIN2 (and MCL1) is
occupied by a conserved glutamate residue (versus a serine
residue in 3BP2), which we predict forms a potent stabilizing
salt bridge interaction (versus weaker hydrogen bond) with
K604TNKS2, as observed in the ARC4:MCL1 complex (Figures
4A and 4D). Furthermore, in comparison to 3BP2, the ARC4-
AXIN1 interaction was less sensitive to the R525ATNKS2 mutation
in the central patch (Figures 3B and S4C). As R525TNKS2 forms
a stabilizing hydrogen bond to the polar side chain of substrate
position 2 (S416 in the case of 3BP2), the presence of a nonpolar
proline in position 2 of AXIN would render R525 more
dispensable.
Thus, although the overall binding mode of substrates to an
ARC of Tankyrase is highly conserved, the relative importance
of component interactions can differ markedly for different
substrates.
Defining Sequence Rules that Govern Substrate
Recognition by Tankyrase
To fully understand the binding determinants within the
TNKS-binding motifs in Tankyrase substrates, we designed a
peptide library based on the TNKS-binding motif of 3BP2. We
serially exchanged each residue of the 8-amino-acid stretch
RSPPDGQS in the fluorescently labeled peptide QRSPPDGQS
for each of the 20 standard amino acids, obtaining 153 unique
peptides. We then used the FP binding assay to test their binding
to ARC4. The results (Figures 5A and S6A and Table S3) can be
rationalized by our ARC:peptide structures.
As expected, peptide recognition by ARC4 critically requires
arginine and glycine residues at positions 1 and 6, respectively.
The arginine cradle is specifically tuned for arginine with multiple
residues collaborating in arginine coordination (see Figures 2B
and 2C). The phi and psi peptide bond angles of glycine at posi-
tion 6 are unique to glycine and cannot be adopted by any othergenesis and Analyzing the Contribution of ARCs to 3BP2 Binding
ues targeted by site-directed mutagenesis are highlighted.
derivable by nonlinear regression using a one-site total binding model; n.q., not
bars, SEM; KD error values, standard error of the fit.
e TNKS2 N terminus (as shown in C) were bacterially produced and probed for
ssay. Bottom panel, Coomassie-stained gel of input samples; middle panel,
ct bound 3BP2.
xpressed with either WT or cherubic (murine R413Q or P416H) FLAG-3BP2 in
owing coexpression; top panels, immunoprecipitates probed with anti-FLAG
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Figure 4. Determinants in TNKS-Binding Motifs for ARC4 Binding
(A) Sequence alignment of TNKS-binding motifs from previously known and proposed human Tankyrase binders; see Extended Experimental Procedures for
accession numbers. Residue numbering within the TNKS-binding motif, as used throughout the analysis, is defined above the alignment. The arrow indicates the
position of an additional alanine in the nonpolymorphic variant of PPP1R12C.
(B) FP binding analysis of peptides corresponding to the TNKS-binding motifs shown in (A). KD are indicated where derivable by nonlinear regression using a
one-site total binding model; n.q., not quantifiable. n = 3 separate experiments performed in technical duplicate; error bars, SEM; KD error values, standard error
of the fit.
(C) FP binding assay analyzing the contribution of the 3BP2 and AXIN1 targeting peptide residues to ARC4 binding. Each one of nine residues was exchanged
for alanine. KD are indicated where derivable by nonlinear regression using a one-site total binding model; n.q., not quantifiable. n = 3 separate experiments
performed in technical duplicate; error bars, SEM; KD error values, standard error of the fit.
(D) Diverse TNKS-binding motifs employ an identical ARC4:peptide binding mode. The sequences of the peptides and peptide chimeras are shown.
See Figures S4 and S5 for additional information. See also Tables S1 and S2.amino acid, explaining why even alanine cannot substitute at
position 6 (Figure S6B).
Positions 2 and 3 of the TNKS-binding motif display a broad
amino acid tolerance. However position 3 poorly tolerated
phenylalanine, and the rank order of the individual residues
was different between the two positions. Consistent with the
broad tolerance, the side chains at positions 2 and 3 of all
peptides in the crystal structures introduced above (Figure 4D)
always face solvent. We cannot rationalize why phenylalanine
is unfavorable at position 3.1348 Cell 147, 1340–1354, December 9, 2011 ª2011 Elsevier Inc.The side chain at peptide position 4 is restricted to the small
and/or hydrophobic amino acids proline, glycine, alanine, and
cysteine. In the crystal structures, side chains at position 4 are
always presented toward the peptide-binding pocket on the
ARC. The space restraints imposed by the position-4 subpocket,
and its hydrophobic nature, explain why only small and hydro-
phobic amino acids are tolerated at this position.
Aspartic acid is strongly preferred at position 5 but can be
substituted to a far lesser degree by glutamic acid, valine, gluta-
mine, tyrosine, isoleucine, and cysteine. In all but one crystal
Figure 5. Defining a Rule-Based Consensus for TNKS-Binding Motifs to Predict Tankyrase Targets
(A) FP-based peptide library screen. Amino acids within the 3BP2-derived octapeptide RSPPDGQS were serially exchanged as indicated. The peptide library
was subjected to an FP binding assaywith ARC4. To obtain KD, data (n = 1 technical duplicate) were analyzed by nonlinear regression using a one-site total binding
model. Colors reflect KD relative to the best binder in each group of 20 peptides per position scanned; n.q., not quantifiable.B indicates native 3BP2 residues;3
indicates cherubism mutations (Lietman et al., 2006; Ueki et al., 2001). See Figure S6 for FP titration graphs and Table S3 for KD. Bottom, sequence logo repre-
senting the sequence rules, derived by dividing the inverse of the KD values by the number of allowed amino acids per position and scaling the letters accordingly.
(B) Affinity optimization of the 3BP2 peptide based on the data shown in (A). The indicated peptides were analyzed by fluorescence polarization. KD were derived
by nonlinear regression using a one-site total binding model. n = 3 separate experiments performed in technical duplicate; error bars, SEM; KD error values,
standard error of the fit.
(C) In silico prediction of human Tankyrase binders based on a position-specific scoring matrix developed from the data shown in (A). Frequency of TTS is plotted
against the corresponding TTS. The inset shows the high-TTS range of the same plot with a smaller TTS frequency scale. Arrows indicate TTS of all peptides
tested by FP and present in the UniProt database for the human proteome.
See Figure S6 for additional information. See also Tables S3, S4, and S7.structure, peptide position 5 is occupied by the highly preferred
aspartate, as in 3BP2, establishing hydrogen bonds to
S527TNKS2. The crystal structures of the ARC4:MCL1 complex
provide an example wherein position 5 is adopted by a hydro-
phobic amino acid (isoleucine). A phenylalanine, F532TNKS2,
and the hydrophobic portion of R525TNKS2 render the position-
5 subpocket sufficiently hydrophobic to accommodate the lessoptimal nonpolar residues identified in the peptide screen (see
Figure 2C).
Position 7 of the TNKS-binding motif can be occupied
by a wide range of amino acids. Surprisingly, proline was
not allowed at this position, presenting a case for
negative selection by the ARC against one particular amino
acid.Cell 147, 1340–1354, December 9, 2011 ª2011 Elsevier Inc. 1349
Position 8 tolerates all 20 amino acids; however, it presents
a substantial preference for acidic residues (glutamate, aspar-
tate) and least prefers basic residues (arginine, lysine). This
is in full agreement with acidic residues in position 8 forming
a salt bridge with K604TNKS2, as observed in the ARC4:MCL1
crystal structure (Figure 4D).
In summary, the findings of the positional scanning experiment
support the binding mode we observe in the ARC4:peptide
complex structures and can explain the ARC-binding behavior
of most of the 16 confirmed or putative TNKS-binding motif
peptides analyzed (see Figure 4A). The experiment also demon-
strates that all characterized cherubism mutations (R415P,
R415Q, P418L, P418R, P418H, D419N, G420E, G420R) act by
abolishing binding of the 3BP2 TNKS-bindingmotif to ARCs (Fig-
ure 5) (Lietman et al., 2006; Ueki et al., 2001). Our peptide library
screen suggests a ‘‘superconsensus’’ for the 8-amino-acid
TNKS-binding motif. To test whether this is the case, we gener-
ated a pair of 10-amino-acid peptides, the first one containing
the TNKS-binding motif of 3BP2 and the second one an opti-
mized TNKS-binding motif with the preferred amino acid at
each position (REAGDGEE).Whereas the peptide corresponding
to 3BP2 bound with an affinity of 4.9 ± 0.4 mM, the sequence-
optimized peptide bound almost an order more tightly, with an
affinity of 0.6 ± 0.04 mM (Figure 5B). Deviations from the super-
consensus at any position, individually or jointly, may allow the
affinity of substrate-targeting peptides to be differentially tuned,
as appears to be the case. Isoleucine at position 5 conferred
weak binding (KD = 72.4 ± 31.6 mM) in the screen, but the
TNKS-binding motif peptide of MCL1, which contains isoleucine
at position 5, bound the ARC robustly (KD = 2.4 ± 0.2 mM). Simi-
larly, valine at position 4 or proline at position 5 were disallowed/
unfavorable in our screen, but AXIN1, another robust ARC binder
(KD = 6.1 ± 0.5 mM), contains exactly these residues at positions
4 and 5. Both of these TNKS-binding motifs contain the stabi-
lizing glutamate residue at position 8, which can form a salt
bridge interaction with K604TNKS2 that likely offsets the negative
impact of suboptimal amino acids at positions 4 and 5. The tar-
geting peptides of both MCL1 and AXIN1 are indeed highly
sensitive to the K604A mutation in ARC4 (Figure S4C and Table
S2). Furthermore, although introduction of the AXIN-like residues
valine and proline at positions 4 and 5, respectively, into the
TNKS-binding motif of 3BP2 abolished measurable binding,
binding was partially restored when either glutamate or aspar-
tate, but not glutamine or asparagine, was present at position
8 (Figure S6C).
An In Silico Prediction of Tankyrase Binders
To identify candidate Tankyrase binders, we performed an
in silico search of the human proteome, using a position-specific
scoring matrix (PSSM) approach based on the affinity data
obtained in the peptide library screen (Yaffe et al., 2001; see
Experimental Procedures for details). We calculated a Tankyr-
ase-targeting score (TTS) of minimally 0.817 (no match) to
maximally 1 (best match) for each peptide in the UniProt data-
base (octapeptide scan with additional scoring of C-terminal
hepta- and hexapeptides; see http://research.lunenfeld.ca/
sicheri/files/file/PSSM_raw_list.txt.zip for a list of all peptides
scored). The vast majority (10,420,456; 93.7%) of the1350 Cell 147, 1340–1354, December 9, 2011 ª2011 Elsevier Inc.11,124,194 peptides scanned obtained a low TTS of <0 (Fig-
ure 5C). Eleven binders of the sixteen previously identified
or predicted Tankyrase targets studied by FP (see Figure 4A)
were enriched in the region of high TTS (Figure 5C). As points
of reference, the prominent Tankyrase targets AXIN1 and
AXIN2 displayed a low TTS of 0.385, due to suboptimal amino
acids at positions 4 and 5 that are disallowed/unfavorable
in the context of 3BP2 (see Figure 5A). All other previously
identified and proposed Tankyrase binders that we observed
to bind ARC4 in the FP assay scored above 0.68. An arbitrary
cutoff at a TTS of 0.77, corresponding to a p value of%0.07, con-
tained only known binders and no proven nonbinders
(Figure 5C).
To reduce the number of unlikely targets in our scoring list, we
additionally filtered the ranked score list for topology (to remove
proteins annotated as extracellular, secreted, lumenal, or mito-
chondrial) and predicted disorder (to remove motifs that reside
in structured regions) (Table S4). The resulting list contains
11,698; 447; and 257 peptide motifs with TTS cutoffs of
R0.385, R0.68, and R0.77, respectively. The apparent large
number (257) and diversity of predicted Tankyrase binders at
the highest stringency cutoff raise the possibility of a previously
underappreciated pervasiveness of Tankyrase-dependent regu-
lation of cellular processes.
Validation of Tankyrase Binders
We probed the validity of our Tankyrase substrate predictions
by using FP to test whether peptides corresponding to a subset
of predicted TNKS-binding motifs can bind ARC4. Out of 17
peptides tested, ranging in TTS from 0.483 to 0.967, 13 (from
the 11 proteins DISC1, STRIATIN, FAT4, RAD54, BCR,MERIT40,
CEP170, FASTK, TAOK2, MYO18B, and DIDO1) tested positive,
whereas 4 (from the 4 proteins APC, TYK2, SMAD7, and LATS2)
tested negative (Figure S7A; TTS highlighted in Figure 5C).
We next tested whether 8 of the 11 positive candidate sub-
strate proteins (i.e., those for which we could generate or obtain
epitope-tagged expression constructs) bound to Tankyrase as
full-length proteins and whether the predicted TNKS-binding
motifs were responsible for binding. We immunoprecipitated
transiently expressed FLAG-tagged variants of Disc1, Striatin,
Fat4 (lacking most of its extracellular portion), RAD54, BCR,
MERIT40, FASTK, and Dido1. Coexpressed MYC-TNKS2 coim-
munoprecipitated with all WT substrate candidates except for
FASTK and Dido1, which expressed too weakly to allow for solid
conclusions (Figure 6 and data not shown). Binding was abol-
ished or reduced by mutation of the predicted TNKS-binding
motifs (G at position 6 to R; equivalent to a cherubism mutation
in 3BP2). In cases where two TNKS-binding motifs were pre-
dicted (Fat4 andMERIT40), bothmotifs contributed to Tankyrase
binding. Using an anti-PAR antibody, we monitored the PARsy-
lation status of these proteins to evaluate whether they were
modified by TNKS2. Disc1, STRIATIN, Fat4, and BCR appeared
strongly PARsylated by Tankyrase, whereas MERIT40 was
weakly PARsylated and RAD54 was not detectably PARsylated
(Figure 6). In all cases where PARsylation was observed, modifi-
cation was sensitive to mutation of the TNKS-binding motifs
(BCR to the least degree) and also dependent on the enzymatic
integrity of the PARP domain of TNKS2.
Figure 6. Validation of Predicted Tankyrase Binders and Substrates
The indicated proteins (FLAG-substrates, see Figure S1A for schematic representations; MYC-TNKS2) were transiently expressed in HEK293T cells (input).
Labels ‘‘mut,’’ ‘‘mut1,’’ ‘‘mut2,’’ and ‘‘mut1+2’’ indicate mutation of the corresponding TNKS-binding motifs (G-to-R at position 6). MYC-TNKS2 ‘‘EA’’
corresponds to catalytically inactive TNKS2 E1138A. FLAG-substrates were immunoprecipitated (IP) and immunoprecipitates analyzed for coprecipitating
MYC-TNKS2 and for the PARsylation status of FLAG-substrates and MYC-TNKS2.C and: indicate expected approximate molecular masses of MYC-TNKS2
and FLAG-substrates, respectively. Sequences and positions of the TNKS-binding motifs (in the human orthologs, from which peptides were derived) are shown
below with their affinities for ARC4, as determined by FP. See Figure S7 for additional information. For BCR, to assess whether the anti-PAR signal corresponds
to MYC-TNKS2 or FLAG-BCR, samples were analyzed using a fluorescence imaging system, which allows for simultaneous probing of the same membrane.
See also Figure S1.
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To test whether binding of the Tankyrase targets was sensitive
to mutation of the peptide-binding pocket in ARCs 1, 2, 4, and 5
and whether endogenous rather than overexpressed Tankyrase
targets can bind the substrate recruitment module of Tankyrase,
we performed GST pull-down experiments from a HEK293T
cell lysate with a bacterially expressed TNKS2 N terminus en-
compassing all five ARCs (His6-GST-TNKS2(20–800), WT, or
xx3xx and xxxxx mutants; see above). Although we were unable
to detect endogenous expression of DISC1 and FAT4 in
HEK293T cells with the antibodies at hand (data not shown),
we detected endogenous expression of RAD54, MERIT40,
BCR, STRIATIN, and TERF1 as a positive control (Figure S7B).
We observed ARC binding by each of the five proteins tested
(Figure S7B). Binding of RAD54 and TERF1 was abolished by
ARC mutations, as predicted, whereas binding of MERIT40,
BCR, and STRIATIN was not greatly affected. These results
suggest that Tankyrase substratesmay be differentially sensitive
to the specific L-to-W ARC mutation employed in this analysis.
Further analysis bore this conclusion out (Figure S7C) and high-
lighted a requirement for compound binding pocket mutations to
each functional ARC to ensure universal abrogation of substrate
recruitment to Tankyrases.
DISCUSSION
In this study, we uncover the structural basis for substrate recog-
nition by Tankyrase, mediated by its N-terminal ankyrin repeats.
This provides a prototypic example for substrate recruitment by a
PARP and also for the means by which an ankyrin repeat protein
can recognize short, extended peptides rather than a globular
protein domain, the more typical function described so far for
ankyrin repeat proteins (reviewed in Li et al., 2006). Given the
sequence similarity of both human Tankyrases, our findings likely
apply to substrate recognition by both TNKS and TNKS2.
We demonstrate that the repeating unit of the Tankyrase N
terminus, the ARC, consists of five stacked ankyrin repeats form-
ing a modular unit and occurs five times within the Tankyrase N
terminus. This clarifies previous uncertainties over the repetitive
character of the Tankyrase N terminus.
The crystal structure of ARC4 bound to the 3BP2 peptide fully
explains how mutations in this sequence lead to a loss of 3BP2
binding that gives rise to cherubism (Lietman et al., 2006; Ueki
et al., 2001). The ARC4-3BP2 binding mechanism appears
universal to ARCs 1, 2, 4, and 5 and is employed for numerous
other Tankyrase substrates, as demonstrated by our crystal
structures of the TNKS-binding motif peptides of TERF1,
MCL1, LNPEP, NUMA1, and FNBP1 bound to ARC4.
Our peptide-binding studies reveal the sequence determi-
nants for low-micromolar-affinity recognition of TNKS-binding
motif peptides by Tankyrase: most importantly, positions 1 and
6 of a functional motif require arginine and glycine, respectively,
whereas the amino acid at position 4 needs to be small and
hydrophobic. The possibilities for position 5 are restricted:
aspartate is strongly preferred, but glutamic acid, valine, gluta-
mine, tyrosine, isoleucine, and cysteine are tolerated as well.
Conversely, the side chains at positions 2 and 3 are solvent
exposed and can thus adopt a wide range of identities. For
such peptides to be recognized by Tankyrase, the amino acid1352 Cell 147, 1340–1354, December 9, 2011 ª2011 Elsevier Inc.at position 7 must not be proline. Glutamate or aspartate at
position 8 positively contribute to Tankyrase binding. Interest-
ingly, most predicted TNKS-binding motifs deviate from the
optimal ‘‘superconsensus,’’ suggesting that their affinity may
be detuned to avoid potentially deleterious effects from too
high affinity. The presence of multiple TNKS-binding motifs in
a single substrate, as demonstrated for MERIT40 and Fat4,
provides a means for increasing affinity beyond levels afforded
by a single motif.
Our consensus-based in silico analysis predicts that a
wide range, possibly hundreds, of proteins may be targeted by
Tankyrase. Our analysis correctly predicts all known and
proposed human Tankyrase binders in the UniProt database,
including the recently identified Tankyrase substrates BLZF1
(UniProt ID GO45_HUMAN) and CASC3 (UniProt ID
CASC3_HUMAN) (Zhang et al., 2011). We identified and vali-
dated six predicted Tankyrase binders, namely the neurogenesis
regulator Disc1, the scaffold protein and PP2A phosphatase
regulatory subunit Striatin, the atypical cadherin Fat4 involved
in Hippo signaling and planar cell polarity, the DNA recombina-
tion protein RAD54, the GTPase-activating protein and Abl
kinase fusion partner BCR, and the DNA repair protein MERIT40.
Recruitment by Tankyrase did not strictly correlate with Tankyr-
ase-mediated PARsylation, indicating that although Tankyrase
binding via the TNKS-binding motif is required for modification,
additional requirements for PARsylation are likely to exist.
Out of five ARCs present in TNKS2, only ARC3, whose sur-
faces are relatively poorly conserved across species (see Fig-
ure S4B), fails to bind TNKS-binding motif peptides. This agrees
with an earlier study in which isolated ARC3, but not other ARCs,
of TNKS failed to bind full-length TERF1, TNKS1BP1, LNPEP,
and an uncharacterized protein termed TNK1BP2 (Seimiya
et al., 2004). A function for ARC3 has yet to be determined.
ARC3 may play a structural role in the context of the full-length
enzyme or engage as-yet-unidentified binding partners in a
way that is difficult to predict from sequence conservation.
Future work is required to establish the contribution of
individual ARCs to substrate PARsylation. In TNKS, ARC5
appears essential for TERF1 PARsylation, release of TERF1
from telomeres, and telomere elongation (Seimiya et al., 2004),
suggesting that at the level of PARP activity, ARCs may not be
functionally interchangeable. ARC5, however, was not sufficient
for TNKS to induce telomere elongation (Seimiya et al., 2004),
suggesting that the collaborative action of multiple ARCs is
needed.
Much attention is currently devoted to the development of
PARP inhibitors, which are of interest as potential anticancer
therapeutics (Lord and Ashworth, 2008; Rouleau et al., 2010).
Although TNKS and TNKS2, through their specific interactions
with many substrates, are involved in a wide variety of biological
processes, inhibition of Tankyrase may hold promise for treating
BRCA1/2-deficient and Wnt-dependent cancers (Huang et al.,
2009; Lord and Ashworth, 2008; McCabe et al., 2009) and a
universal anticancer activity through the stabilization of TERF1
and a concomitant inhibition of telomerase function (Ancelin
et al., 2002; Chong et al., 1995; Sbodio andChi, 2002; van Steen-
sel and de Lange, 1997). All PARP inhibitors characterized to
date compete with NAD+. The universality of NAD+ as an
enzymatic cofactor and the likely emergence of drug resistance
are two major challenges in pharmaceutical PARP inhibition (Ed-
wards et al., 2008; Lord and Ashworth, 2008; Rouleau et al.,
2010; Sakai et al., 2008). Our advancing understanding of sub-
strate recognition by Tankyrases opens avenues for the develop-
ment of Tankyrase substrate antagonists, which would address
questions of specificity and possibly resistance. Given our
evidence for functional redundancy of different ARCs, such
antagonists may need to recognize all active ARCs.
EXPERIMENTAL PROCEDURES
Extended Experimental Procedures are available in the Supplemental
Information online. Lists of plasmids and peptides used in this study are given
in Tables S5 and S6.
Protein Expression, Crystallization, and Structure Determination
Purified human TNKS2 ARC constructs included residues 20–178 (ARC1),
173–487 (ARC2-3), 488–649 (ARC4) or 484–655 for apo-ARC4 structure,
641–800 (ARC5), and 20–800 (ARC1-5). Equivalent ARC mutations (denoted
by ‘‘x’’) were L92W (ARC1), L245W (ARC2), L401W (ARC3), L560W (ARC4),
and L713W (ARC5). All crystals were grown at 20C in hanging drops bymixing
one volume of protein solution with one volume of precipitant solution. See
Extended Experimental Procedures for details on expression plasmids,
protein expression and purification, peptides, protein concentrations, precip-
itant solutions, cryoprotectants, and data collection and structure determina-
tion methodologies.
FP Binding Assays
Binding reactions were performed with 25 nM fluorophore-conjugated peptide
and the indicated protein concentrations in 50 mM HEPES-NaOH (pH 7.5),
100 mM NaCl, 2 mM TCEP, 80 mg/ml BSA. For Figures 1B, S4A, and S5, the
FP buffer contained 300 mM NaCl and 10% glycerol. Nonlinear regression
with FP values was performed in GraphPad Prism 5 using a one-site total
binding model.
GST Pull-Down Assay
For Figure 3D, His6-GST-TNKS2(20–800) and mutants were immobilized on
glutathione Sepharose and incubated with 48 mg purified murine His6-3BP2
each in 50 mM HEPES-NaOH (pH 7.5), 300 mM NaCl, 2 mM DTT, 0.5 mM
PMSF (total volume: 250 ml) for 90 min at 4C. The resin was washed six times
with binding buffer (without PMSF). Input and pull-down samples were
analyzed by SDS-PAGE, Coomassie staining (input), or western blotting with
a FLAG-tagged anti-3BP2 Fab (1 ng/ml) and anti-FLAG M2-HRP.
Coimmunoprecipitation
For Figure 3E, HEK293T cells were transfected with expression plasmids
for the indicated MYC-TNKS2 and FLAG-3BP2 derivatives or empty vector.
After 24 hr, cells were lysed in 25 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1%
Triton X-100, 1mMNa3VO4, 5mMEDTA, and protease inhibitors. Immunopre-
cipitation with soluble, precleared lysates was performed with anti-FLAG
M2-agarose for 1 hr at 4C. Immunoprecipitates were washed three times
with lysis buffer.
For Figure 6, HEK293T cells were transfected with expression plasmids for
MYC-TNKS2 (wild-type or PARP-dead E1138A), FLAG-substrate candidates
(wild-type or G6R), or empty vector. Cells were cotransfected with domi-
nant-negative PARG to limit PAR hydrolysis. After 20–24 hr, cells were lysed
in 50 mM HEPES-NaOH (pH 7.5), 150 mM NaCl, 0.1% SDS, 0.5% sodium de-
oxycholate, 1% Triton X-100, 5 mM EDTA (pH 8.0), 2 mM ADP-HPD (PARG
inhibitor), 5 mM DTT, and protease inhibitors. FLAG-substrate candidates
were immunoprecipitated using anti-FLAG M2-agarose for 90 min at 4C.
Immuoprecipitates were washed five times with lysis buffer (without protease
inhibitors and ADP-HPD). Lysates and immunoprecipitates were analyzed by
SDS-PAGE and western blotting with anti-MYC 9E10, anti-FLAG M2, and
polyclonal anti-PAR antibodies.In Silico Tankyrase Substrate Prediction
An 83 20 PSSM (shown in Table S7) was generated using the ARC4 affinities
for the peptides in the positional scanning peptide library (Table S3). To score
heptapeptides or hexapeptides at the extreme C terminus of proteins, the
scoring matrix was truncated after positions 7 or 6. All possible octapeptides,
one heptapeptide, and one hexapeptide were scored according to this matrix
for each human protein in the UniProt database (release v1.37). A TTS was
calculated using the formula
TTS=
Pn
pos:=1
PSSMpos:
max
 Pn
pos:= 1
PSSMpos:
!
with n = number of amino acids in peptide scored (6–8).
See Extended Experimental Procedures for additional details and filtering
procedures.
ACCESSION NUMBERS
Structure coordinates and structure factors have been deposited in the Protein
Data Bank under ID codes 3TWQ (apo-ARC4), 3TWR (ARC4:3BP2), 3TWS
(ARC4:TERF1 chimera), 3TWT (ARC4:MCL1 chimera), 3TWU (ARC4:MCL1),
3TWV (ARC4:NUMA1 chimera), 3TWW (ARC4:LNPEP chimera), and 3TWX
(ARC4:FNBP1 chimera).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
doi:10.1016/j.cell.2011.10.046.
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